Publication:
THE IMPORTANCE OF CUTANEOUS SILENT PERIOD IN UREMIC POLYNEUROPATHY

dc.contributor.authorsKayacan, Seyit Mehmet; Isak, Baris; Kayacan, Dilek; Muftuoglu, Muharrem; Karadag, Aytac
dc.date.accessioned2022-03-12T18:04:51Z
dc.date.accessioned2026-01-11T14:03:42Z
dc.date.available2022-03-12T18:04:51Z
dc.date.issued2011
dc.description.abstractObjective: Cutaneous silent period (CSP) is a brief pause in a voluntary contraction following strong stimulation of a cutaneous nerve. Clinical interest in the CS P sterns from its potential usefulness for evaluating segment and components of sensory nerves that are not well assessed by standard electro diagnostic methods. Aim of this study was to determine whether CSP has precedence over standard nerve conduction studies (SNCS) in uremic polyneuropathy Material and Method: The study included 20 chronic hemodialysis patients. Mean age was 42.6 (22-63). Mean uremic period before dialysis and dialysis age were 13.9+7.2 (6-36) and 51.2+46.8 months (12-190), respectively. The eight of patients were symptomatic (paresthesia, pain-burning), the others were asymptomatic. Twenty healthy volunteers were accepted as control group. Standard sensorial and motor nerve conductions and F- responses were recorded in patients. Cutaneous silent period were measured from abductor pollicis brevis (APB) muscle by stimulating third finger and from tibialis anterior muscle by stimulating sural nerve. Results: The significant difference between dialysis and control groups was not found in SNCS. But, at the recording from APB muscle, CSP latency (ms) (82.44+7.80) in hemodialysis patients was longer than controls (63.60+13.70) (p<0.001) and CSP duration (ms) (42.10+9.95) was significantly shorter than controls (51.54+11.24) (p<0.001). At the recording from tibialis anterior muscle, CSP latency (101.90+13.38) was similar with controls (95.03+12.59) (0.1<p<0.5) and CSP duration (34.12+16.09) was significantly shorter than controls (52.95+18.13) (p<0.001). Conclusion: The shortening of CSP duration was thought an antecedent and important method for uremic polyneuropathy as thin fiber neuropathy.
dc.identifier.doidoiWOS:000297782400016
dc.identifier.issn1305-2381
dc.identifier.urihttps://hdl.handle.net/11424/230485
dc.identifier.wosWOS:000297782400016
dc.language.isoeng
dc.publisherNOBEL ILAC
dc.relation.ispartofNOBEL MEDICUS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCutaneous silent period
dc.subjectpolyneuropathy
dc.subjecturemia
dc.subjectSTIMULATION
dc.titleTHE IMPORTANCE OF CUTANEOUS SILENT PERIOD IN UREMIC POLYNEUROPATHY
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage94
oaire.citation.issue3
oaire.citation.startPage89
oaire.citation.titleNOBEL MEDICUS
oaire.citation.volume7

Files